EV maker Nio’s stock has come back from the dead in 2025, but has it been good for long-time investors? Shares of Chinese electric vehicle (EV) maker Nio (NIO +0.60%) surprised the market as they soared more than 120% between July and October. Even though the stock has given up some of those gains, it’s… Continue reading Evaluating Nio Stock’s Actual Performance
Tag: People
The 4th China International Supply Chain Expo Set for Beijing in June 2026
Sustained Worldwide Outreach Drives Greater Collaboration Opportunities BEIJING, Dec. 7, 2025 /PRNewswire/ — The 4th China International Supply Chain Expo (“CISCE,” “the Expo”) will be held in Beijing from June 22 to 26, 2026. To date, more than 300 companies have signed up to exhibit, with preparations moving forward smoothly. Continue Reading From November 30 to… Continue reading The 4th China International Supply Chain Expo Set for Beijing in June 2026
HALLMARK PRESENTS A DISNEY LOVE STORY
TWO ICONIC BRANDS TEAM UP TO CREATE AN UNFORGETTABLE HOLIDAY ADVENTURE LACEY CHABERT AND TRAVIS VAN WINKLE FIND UNEXPECTED MAGIC AND ROMANCE IN HOLIDAY EVER AFTER: A DISNEY WORLD WISH COME TRUE DEBUTING IN 2026 DURING HALLMARK CHANNEL’S 17TH ANNUAL COUNTDOWN TO CHRISTMAS PROGRAMMING EVENT Richard Kind, Christy Carlson Romano and Patrick Renna Also Join… Continue reading HALLMARK PRESENTS A DISNEY LOVE STORY
All Approved Indications of Five Akeso’s Innovative Drugs Included in China’s Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs
HONG KONG, Dec. 7, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced the successful inclusion of all five of the Company’s self-developed innovative drugs into the updated National Reimbursement Drug List (NRDL) for 2025, released by China’s National Healthcare Security Administration (NHSA), effective January 1, 2026. These inclusions cover both newly added… Continue reading All Approved Indications of Five Akeso’s Innovative Drugs Included in China’s Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs
@VW Group: Porsche creates global opportunities for young professionals011027
Theresa, what makes sustainability especially important to you? Theresa Boyle: For me, sustainability means taking responsibility – for the environment, society, and especially for leaving our children a fair, intact world. Personally, the social dimension of sustainability is particularly important to me. This includes topics like equal opportunities, participation, and inclusion. When we think about… Continue reading @VW Group: Porsche creates global opportunities for young professionals011027
Researchers Concerned to Find That Five-Year-Olds Are Already Deeply Hooked on Brain Rot Content
Getty / Futurism The brains of neurotypical children under the age of five years old experience a turbo-charged growth spurt that takes them from drooling infants to potty-trained kids ready to learn their ABCs in school. That’s why it’s so worrisome that we’re inadvertently subjecting a large group of these children to an epic amount… Continue reading Researchers Concerned to Find That Five-Year-Olds Are Already Deeply Hooked on Brain Rot Content
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China’s National Reimbursement Drug List
SAN FRANCISCO and SUZHOU, China, Dec. 6, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that seven of its innovative products have been included in the updated 2025 National… Continue reading Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China’s National Reimbursement Drug List
SK hynix Honored with Two Major Titles at GSA Awards 2025
Company named “Best Financially Managed Semiconductor Company (Achieving Greater than $1 Billion in Annual Sales)” and “Outstanding Asia-Pacific Semiconductor Company” simultaneously Accelerates recovery from market downturn leveraging world-class HBM leadership; Global management performance recognized Reflects company’s technology leadership and customer-centric execution SK Chairman Chey Tae-won emphasizes: “Technological competitiveness must remain unwavering in challenging times” Commits… Continue reading SK hynix Honored with Two Major Titles at GSA Awards 2025
MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users
New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance of protein-focused nutrition. BOSTON, Dec. 6, 2025 /PRNewswire/ — MENU – ORDER AI, the first real-time GLP-1 dining companion designed to guide users toward High-protein and GLP-1 friendly meal choices, announced that the app now supports a growing international audience… Continue reading MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users
MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users
New multilingual capabilities expand access to real-time GLP-1 dining guidance as WHO highlights the importance of protein-focused nutrition. BOSTON, Dec. 6, 2025 /PRNewswire/ — MENU – ORDER AI, the first real-time GLP-1 dining companion designed to guide users toward High-protein and GLP-1 friendly meal choices, announced that the app now supports a growing international audience… Continue reading MENU – ORDER AI Announces Global Expansion with New Multilingual Capabilities, Supporting WHO Guidance on Dietary Needs for GLP-1 Users